OMN-XGP

N/A

Report date: 2025/01/26 16:32:30

Base Information

Drug NameOMN-XGP
Drug Alias NamePeptide for multidrug-resistant pathogenic gram-positive bacterial infection/MRSA infection (Omnix Medial)OMN-XGP
ClassificationSmall molecules > Heterocyclic drugs > AntibioticsBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAntibacterial multidrug resistance inhibitors
TargetsUpdating
Therapy Area/IndicationsMultidrug-Resistant InfectionStaphylococcal InfectionsGram-Positive Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOmnix Medical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOmnix Medical Ltd
Inactive CompaniesN/A
Active IndicationsMultidrug-Resistant InfectionStaphylococcal InfectionsGram-Positive Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A